Journal of Medicinal Chemistry · 2010 · 46 citations · 18 references
PharmacyChemistryMedicinal ChemistryDrug DesignOrganic ChemistryStructure-activity RelationshipsDna ChemistryHeterocyclic ChemistryLead Compound DesignLigand BindingLigand-based DesignStructure-activity Relationship AnalysisAgarose Gel ElectrophoresisBinding ProcessesCircular DichroismCircular Dichroism AnalysisFluorescence Emission SpectraGel ElectrophoresisPolyacrylamide Gel ElectrophoresisQuinoline Chemistry
New N-alkylanilinoquinazoline derivatives 5, 12, 20, and 22 have been prepared from 4-chloro-6,7-dimethoxyquinazoline 3, 4-chloro-6,7-methylenedioxyquinazoline 19, and commercially available anilines. Differents classes of compounds substituted by an aryloxygroup (6a-c, 16a,b, and 17a,b), (aminophenyl)ureas (12a,b and 13a-f), anilines (4a-m, 20a,b), N-alkyl(aniline) (5a-m, 21a,b, 22a,d), and N-aminoalkyl(aniline) (22e-g) have been synthesized. These molecules were evaluated for their cytotoxic activities and as potential DNA intercalating agents. We studied the strength and mode of binding to DNA of these molecules by DNA melting temperature measurements, fluorescence emission, and circular dichroism. The results of various spectral and gel electrophoresis techniques obtained with the different compounds, in particular compounds 5g and 22f, revealed significant DNA interaction. These experiments confirm that the N-aminoalkyl(anilino)-6,7-dimethoxyquinazoline nucleus is an efficient pharmacophore to trigger binding to DNA, via an intercalative binding process.
18
Alexander J. Bridges, Hairong Zhou, Donna R. Cody et al. · Journal of Medicinal Chemistry · 1996 · 322 citations · Full text
Trudi A. Gourdie, Kisione K. Valu, G. Lance Gravatt et al. · Journal of Medicinal Chemistry · 1990 · 78 citations